--- license: cc-by-4.0 task_categories: - tabular-classification language: - en tags: - synthetic - healthcare - snakebite - envenomation - antivenom - neglected-tropical-disease - toxicology - sub-saharan-africa - lmic pretty_name: Snakebite Envenomation Dataset (Species, Syndrome, Antivenom, Complications) size_categories: - 10K ⚠️ **Synthetic dataset** — Parameterized from published SSA literature, not real observations. Not suitable for empirical analysis or policy inference. # Snakebite Envenomation Dataset ## Abstract This dataset provides **30,000 synthetic snakebite records** (10,000 per scenario) from sub-Saharan African health facilities. Each record contains 35 variables including snake species (9 taxa), envenomation syndrome (cytotoxic/hemotoxic/neurotoxic), severity grading, clinical features (swelling, coagulopathy, neurotoxicity, necrosis, AKI), antivenom treatment, surgical interventions, and outcomes. Three facility scenarios range from referral hospitals with antivenom (3.6% mortality) to rural health centres without antivenom (22.0% mortality), reflecting the devastating impact of the antivenom access gap. ## 1. Introduction Snakebite envenomation causes ~315,000 envenomations and ~32,000 deaths annually in SSA (Chippaux, *Toxicon* 2011), with ~7,000 amputations. WHO classified snakebite as a category A neglected tropical disease in 2017. The most medically important genera include *Echis* (carpet vipers — coagulopathy), *Bitis* (puff adders — cytotoxicity), *Naja* (cobras — necrosis/neurotoxicity), and *Dendroaspis* (mambas — rapid neurotoxicity). Antivenom access meets <2% of need in SSA (Schioldann et al., *PLoS NTD* 2018), and mean time to treatment ranges from 6–24 hours. **This dataset is entirely synthetic. It must not be used for clinical decision-making.** ## 2. Methodology ### 2.1 Epidemiological Parameterization | Parameter | Value | Source | | --- | --- | --- | | SSA envenomations/year | ~315,000 | Chippaux, Toxicon 2011 | | SSA deaths/year | ~32,000 | Chippaux, 2011 | | Global deaths | 81,000–138,000 | Kasturiratne et al., PLoS Med 2008 | | Antivenom access (SSA) | <2% of need | Schioldann et al., PLoS NTD 2018 | | Dry bite rate | ~20% | Warrell, Lancet 2010 | | Echis coagulopathy rate | 70–80% | Habib et al., PLoS NTD 2015 | | Case fatality (with antivenom) | 2–5% | Habib et al., 2015 | | Case fatality (without antivenom) | 10–20% | Multiple SSA studies | | Antivenom reaction rate | ~15% | Gutierrez et al., Nat Rev 2017 | ### 2.2 Scenario Design | Scenario | Setting | Antivenom Access | Mean Time (hrs) | Mortality | | --- | --- | --- | --- | --- | | Referral hospital | Tertiary, antivenom stock | 70% | 4.8 | 3.6% | | District hospital | Intermittent supply | 35% | 9.4 | 10.1% | | Rural health centre | No antivenom, referral needed | 5% | 18.9 | 22.0% | ## 3. Schema | Column | Type | Description | | --- | --- | --- | | id | int | Unique identifier | | age_years | int | Patient age | | sex | categorical | M / F | | occupation | categorical | farmer / herder / hunter / trader / student / child / other | | bite_location | categorical | foot / ankle / lower_leg / hand / forearm / other | | activity_at_bite | categorical | farming / walking / sleeping / herding / collecting_firewood / other | | time_to_facility_hours | float | Hours from bite to facility arrival | | traditional_treatment_first | binary | Sought traditional healer before hospital | | snake_species | categorical | 9 taxa (Echis, Bitis, Naja, Dendroaspis, etc.) | | dry_bite | binary | No envenomation | | envenomation_syndrome | categorical | cytotoxic / hemotoxic / neurotoxic / mixed / cardiotoxic / none | | severity | categorical | mild / moderate / severe / none | | local_swelling | binary | Local tissue swelling | | local_necrosis | binary | Tissue necrosis at bite site | | coagulopathy | binary | Venom-induced consumption coagulopathy | | inr_elevated | binary | Elevated INR | | bleeding | binary | Clinical bleeding | | neurotoxicity | binary | Neurotoxic signs | | ptosis | binary | Drooping eyelids (neurotoxicity marker) | | respiratory_failure | binary | Respiratory paralysis | | acute_kidney_injury | binary | AKI | | compartment_syndrome | binary | Compartment syndrome | | antivenom_given | binary | Antivenom administered | | antivenom_vials | int | Number of antivenom vials | | antivenom_reaction | binary | Adverse reaction to antivenom | | wound_care | binary | Wound care provided | | fasciotomy | binary | Fasciotomy performed | | blood_transfusion | binary | Blood transfusion given | | mechanical_ventilation | binary | Mechanical ventilation | | dialysis | binary | Dialysis for AKI | | amputation | binary | Amputation required | | antibiotics_given | binary | Antibiotics administered | | outcome | categorical | survived_full_recovery / survived_with_sequelae / survived_with_disability / died | | hospital_days | int | Length of hospital stay | ## 4. Validation

Validation Report

Key validation checks: - **Antivenom-mortality inverse**: Referral 70% access/3.6% mortality vs rural 5%/22.0% ✓ - **Severity-mortality gradient**: Mild ~2% → moderate ~10% → severe ~20% ✓ - **Species-syndrome concordance**: Echis→hemotoxic, Bitis→cytotoxic, mamba→neurotoxic ✓ - **Male predominance**: 65% male, consistent with agricultural risk ✓ - **Time to facility**: Rural 19 hrs >> referral 5 hrs ✓ ## 5. Usage ```python from datasets import load_dataset dataset = load_dataset("electricsheepafrica/snakebite-envenomation", "district_hospital") df = dataset["train"].to_pandas() ``` ```bash python generate_dataset.py --all-scenarios --n 10000 --seed 42 ``` ## 6. Limitations - **Synthetic**: Not derived from real clinical records. - **No venom assays**: No venom levels or specific venom component data. - **Simplified species ID**: Real-world species identification often uncertain. - **No coagulation kinetics**: No serial INR/PT/APTT trajectories. - **No wound photographs**: Clinical features are categorical, not visual. - **No seasonal variation**: Bite incidence does not vary by season/rainfall. ## 7. References 1. Chippaux JP (2011). Estimate of the burden of snakebites in SSA. *Toxicon*, 57(4):586–599. 2. WHO (2019). Snakebite envenoming: a strategy for prevention and control. 3. Habib AG, et al. (2015). Echis ocellatus envenoming in Nigeria. *PLoS NTD*, 9(1):e3479. 4. Warrell DA (2010). Snake bite. *Lancet*, 375(9708):77–88. 5. Harrison RA, et al. (2009). Snakebite: disease of poverty. *PLoS NTD*, 3(12):e569. 6. Kasturiratne A, et al. (2008). Global burden of snakebite. *PLoS Med*, 5(11):e218. 7. Gutierrez JM, et al. (2017). Snakebite envenoming. *Nat Rev Dis Primers*, 3:17063. 8. Schioldann E, et al. (2018). Antivenom availability in SSA. *PLoS NTD*, 12(12):e0006828. ## Citation ```bibtex @dataset{esa_snakebite_2025, title={Snakebite Envenomation Dataset}, author={Electric Sheep Africa}, year={2025}, publisher={Hugging Face}, url={https://huggingface.co/datasets/electricsheepafrica/snakebite-envenomation} } ``` ## License [CC-BY-4.0](https://creativecommons.org/licenses/by/4.0/)